202 related articles for article (PubMed ID: 9462518)
21. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation.
Castigli E; Alt FW; Davidson L; Bottaro A; Mizoguchi E; Bhan AK; Geha RS
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12135-9. PubMed ID: 7527552
[TBL] [Abstract][Full Text] [Related]
22. NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells.
Mora A; Youn J; Keegan A; Boothby M
J Immunol; 2001 Feb; 166(4):2218-27. PubMed ID: 11160275
[TBL] [Abstract][Full Text] [Related]
23. A critical role for IL-21 in regulating immunoglobulin production.
Ozaki K; Spolski R; Feng CG; Qi CF; Cheng J; Sher A; Morse HC; Liu C; Schwartzberg PL; Leonard WJ
Science; 2002 Nov; 298(5598):1630-4. PubMed ID: 12446913
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporin-A sensitive induction of NF-AT in murine B cells.
Venkataraman L; Francis DA; Wang Z; Liu J; Rothstein TL; Sen R
Immunity; 1994 Jun; 1(3):189-96. PubMed ID: 7889407
[TBL] [Abstract][Full Text] [Related]
25. Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
Good L; Maggirwar SB; Sun SC
EMBO J; 1996 Jul; 15(14):3744-50. PubMed ID: 8670878
[TBL] [Abstract][Full Text] [Related]
26. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
[TBL] [Abstract][Full Text] [Related]
27. NFATc1 and NFATc2 together control both T and B cell activation and differentiation.
Peng SL; Gerth AJ; Ranger AM; Glimcher LH
Immunity; 2001 Jan; 14(1):13-20. PubMed ID: 11163226
[TBL] [Abstract][Full Text] [Related]
28. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells.
Chuvpilo S; Zimmer M; Kerstan A; Glöckner J; Avots A; Escher C; Fischer C; Inashkina I; Jankevics E; Berberich-Siebelt F; Schmitt E; Serfling E
Immunity; 1999 Feb; 10(2):261-9. PubMed ID: 10072078
[TBL] [Abstract][Full Text] [Related]
29. Lymphocytes lacking I kappa B-alpha develop normally, but have selective defects in proliferation and function.
Chen CL; Singh N; Yull FE; Strayhorn D; Van Kaer L; Kerr LD
J Immunol; 2000 Nov; 165(10):5418-27. PubMed ID: 11067893
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the constitutive and inducible components of a T cell IL-4 activation responsive element.
Tara D; Weiss DL; Brown MA
J Immunol; 1995 May; 154(9):4592-602. PubMed ID: 7722312
[TBL] [Abstract][Full Text] [Related]
31. The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells.
Schuh K; Twardzik T; Kneitz B; Heyer J; Schimpl A; Serfling E
J Exp Med; 1998 Oct; 188(7):1369-73. PubMed ID: 9763616
[TBL] [Abstract][Full Text] [Related]
32. IL-4 suppression of in vivo T cell activation and antibody production.
Morris SC; Gause WC; Finkelman FD
J Immunol; 2000 Feb; 164(4):1734-40. PubMed ID: 10657618
[TBL] [Abstract][Full Text] [Related]
33. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.
Whisler RL; Beiqing L; Chen M
Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546
[TBL] [Abstract][Full Text] [Related]
34. Suppression of IL-2 and IL-4 gene expression by nodularin through the reduced NF-AT binding activity.
Yea SS; Kim HM; Jeon YJ; Oh HM; Jeong HG; Yang KH
Toxicol Lett; 2000 Apr; 114(1-3):215-24. PubMed ID: 10713487
[TBL] [Abstract][Full Text] [Related]
35. Restraint of B cell activation by Foxj1-mediated antagonism of NF-kappa B and IL-6.
Lin L; Brody SL; Peng SL
J Immunol; 2005 Jul; 175(2):951-8. PubMed ID: 16002694
[TBL] [Abstract][Full Text] [Related]
36. In vivo inhibition of NF-kappa B in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis.
Ferreira V; Sidénius N; Tarantino N; Hubert P; Chatenoud L; Blasi F; Körner M
J Immunol; 1999 Jun; 162(11):6442-50. PubMed ID: 10352258
[TBL] [Abstract][Full Text] [Related]
37. Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP.
Shapiro VS; Mollenauer MN; Weiss A
J Immunol; 1998 Dec; 161(12):6455-8. PubMed ID: 9862666
[TBL] [Abstract][Full Text] [Related]
38. Expression and biological activities of bovine interleukin 4: effects of recombinant bovine interleukin 4 on T cell proliferation and B cell differentiation and proliferation in vitro.
Estes DM; Hirano A; Heussler VT; Dobbelaere DA; Brown WC
Cell Immunol; 1995 Jul; 163(2):268-79. PubMed ID: 7606798
[TBL] [Abstract][Full Text] [Related]
39. Regulation of expression of the IL-2 and IL-5 genes and the role of proteins related to nuclear factor of activated T cells.
Tsuruta L; Lee HJ; Masuda ES; Yokota T; Arai N; Arai K
J Allergy Clin Immunol; 1995 Dec; 96(6 Pt 2):1126-35. PubMed ID: 8543769
[TBL] [Abstract][Full Text] [Related]
40. STAT6, NF-kappaB and C/EBP in CD23 expression and IgE production.
Tinnell SB; Jacobs-Helber SM; Sterneck E; Sawyer ST; Conrad DH
Int Immunol; 1998 Oct; 10(10):1529-38. PubMed ID: 9796920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
